MENU

Lipocine (LPCN) Ownership - Who owns Lipocine?

Profile

Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.57M
P/E Ratio
N/A
Total Cash
22.55M
Projected Growth
N/A
Total Debt
1.48M
Revenue
4.8M
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
4.22
Total Debt/Equity
N/A
Revenue/Share
0.89 USD as % of share price

Fundamentals

LPCN
Capitalization
19.6M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
22.5M
Total Cash/Share
4.22
Total Debt
1.48M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.89%
Revenue
4.8M
ROE
N/A
Book Value
21.2M
P/B Ratio
0.92
Cash Flow
N/A
Earnings
-1.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.86K
Current Ratio
12.56
Current Revenue Per Employee
5268.53
Dividends Per Share - Security
N/A
EBITDA
-8.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
-1993.14
Revenue To Assets
-31.72
Shares Held By Institutions
5.55M
Shares Outstanding - Current
5.35M
Total Liabilities
1.82M
Total Volume MTD
N/A
Value
N/A
Gain YTD
34.050
View a ticker or compare two or three
LPCN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com